ACT UP Applauds New York City Department of Health's Use of Pre-Exposure Prophylaxis to Reduce HIV
January 29, 2014
This article was reported by Edge on the Net.
Edge on the Net reported that the AIDS Coalition to Unleash Power/New York (ACT UP/NY) praised New York State's Department of Health (NYS DOH) AIDS Institute for releasing pre-exposure prophylaxis (PrEP) guidelines for preventing HIV transmission in at-risk individuals. PrEP means taking the antiretroviral Truvada prior to exposure to prevent HIV. Terry Roethlein, an ACT UP member, attributed the release of the PrEP guidelines on January 14, 2014, to ACT UP pressure and communication with NYS DOH AIDS Institute.
The US Food and Drug Administration approved Truvada's use of PrEP in July 2012. Since that time, 5,000 individuals in New York have received HIV diagnoses, according to CDC data. ACT UP is demanding that New York State take specific measures to reduce state infection rates.
Act UP recommended PrEP-related continuing education courses for healthcare providers and public education campaigns for healthcare providers and the public, particularly for at-risk communities such as men who have sex with men (MSM), young MSM of color, and transgender women. Suggestions also include funding for healthcare organizations to make PrEP available to at-risk poor and uninsured individuals as well as to provide material on available resources.
ACT UP/NY also would like certain commitments from the governor and state that would help reduce transmission and lower viral loads, including use of newer methods such as PrEP and post-exposure prophylaxis.
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)